There are 2867 resources available
298P - Stable, controllable, and scalable manufacturing of B7-H3 UCAR-T, an allogeneic CAR-T product for advanced glioma, from healthy donors
Presenter: Haijuan Jiang
Session: Poster session 02
878P - Improved proteome coverage for cancer plasma-derived extracellular vesicles (pEVs) using high-resolution isoelectric focusing (HiRIEF) LC-MS
Presenter: Nidhi Sharma
Session: Poster session 04
879P - Whole-genome landscape of head and neck melanomas in East Asia (China)
Presenter: Xuan Wang
Session: Poster session 04
880P - Phase II trial of the cyclin dependent kinase 4/6 inhibitor SHR6390 in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification
Presenter: Chaoji Shi
Session: Poster session 04
881TiP - NEOplus: A phase II study of neoadjuvant lenvatinib and pembrolizumab in resectable mucosal melanoma
Presenter: Lili Mao
Session: Poster session 04
882TiP - Subcutaneous vs intravenous nivolumab in patients with melanoma following complete resection
Presenter: Paolo Ascierto
Session: Poster session 04
883TiP - A phase I/II open-label study (IOV-GM1-201) of TALEN-mediated PD-1 inactivated autologous tumor-infiltrating lymphocytes (TIL; IOV-4001) in patients with advanced melanoma and NSCLC
Presenter: Jason Chesney
Session: Poster session 04
884TiP - A phase Ib/II multicenter, randomized, umbrella study evaluating novel treatment combinations in melanoma (MORPHEUS-MELANOMA)
Presenter: Georgina Long
Session: Poster session 04
934P - Clinical and genomic characteristics of non-small cell lung cancer in young patients under 40 years old
Presenter: tianyu Yao
Session: Poster session 04